Topics
Media
Pearls
Surveys
Conferences
Events
CME/CE
Resources
Subscribe

Spotlight -

Healthcare Careers|

Utilizing Medical Malpractice Data to Mitigate Risks and Reduce Claims

|Videos|October 23, 2020

Financial performance metrics and goals for physicians

Author(s)Drew Boxler, Logan Lutton

R1 measures roughly 39 metrics in the financial clearance process

R1 measures roughly 39 metrics in the financial clearance process. What’s more important is setting up in-process and outcome metrics. Learn more from our discussion with Dan Dooley, VP of physician services at R1.

Newsletter

Optimize your practice with the Physicians Practice newsletter, offering management pearls, leadership tips, and business strategies tailored for practice administrators and physicians of any specialty.

Related Content

Off the Chart: A Business of Medicine Podcast - Ep. 98: Fighting burnout, with Stefanie Simmons, M.D., FACEP, CMO of the Dr. Lorna Breen Heroes’ Foundation

Fighting burnout, with Stefanie Simmons, M.D., FACEP, CMO of the Dr. Lorna Breen Heroes’ Foundation

ByAustin Littrell

November 3rd 2025

Preparing before ICE arrives

Preparing before ICE arrives

ByKatie P. Russell, J.D.

October 31st 2025

Neil Baum, M.D.

3 lessons from the trenches

ByNeil Baum, MD

October 31st 2025

Rachel V. Rose, JD, MBA

The spooky side of med spas

ByRachel V. Rose, JD, MBA

October 31st 2025

Marketing strategy | © STOATPHOTO - adobe.stock.com

How do I create a marketing plan for a medical practice?

ByKeith A. Reynolds

October 30th 2025

Latest CME

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

© 2025 MJH Life Sciences^®

All rights reserved.